Michael Jäger - Concepedia

Author

Michael Jäger

Pharmalog (Germany)ORCID

Also Known As

Hans Wolf, M Jäger, M. Jäger, Michael Andreas Jäger, Michael Jäger, Michael Jäger

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Pharmalog (Germany)Neovii Biotech (Germany)Ludwig-Maximilians-Universität München Charité - Universitätsmedizin Berlin University of Regensburg

About

Michael Jäger is an author at Pharmalog (Germany) specializing in medicine, tumor microenvironment, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	244
2	Immunology	2	2	209
3	Health Sciences	1	1	22
4	Public Health	1	1	59
5	Cell Biology	1	1	93

Michael Jäger

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Effective Relief of Malignant Ascites in Patients with Advanced Ovarian Cancer by a Trifunctional Anti-EpCAM × Anti-CD3 Antibody: A Phase I/II Study Alexander Burges, Pauline Wimberger, Carolin Kümper, Clinical Cancer Research	2007	253
Phase I Trial of the Trifunctional Anti-HER2 × Anti-CD3 Antibody Ertumaxomab in Metastatic Breast Cancer Philipp Kiewe, Stephan Hasmüller, Steffen Kahlert, Clinical Cancer Research	2006	194
Immunomonitoring Results of a Phase II/III Study of Malignant Ascites Patients Treated with the Trifunctional Antibody Catumaxomab (Anti-EpCAM × Anti-CD3) Michael Jäger, A. Schoberth, Peter Ruf, Cancer Research ImmunologyPathologyImmunotherapeuticsCatumaxomab TherapyImmunotherapy	2011	116
Characterisation of the new EpCAM-specific antibody HO-3: implications for trifunctional antibody immunotherapy of cancer Peter Ruf, Olivier Gires, Michael Jäger, British Journal of Cancer	2007	100
The Trifunctional Antibody Ertumaxomab Destroys Tumor Cells That Express Low Levels of Human Epidermal Growth Factor Receptor 2 Michael Jäger, A. Schoberth, Peter Ruf, Cancer Research Tumor BiologyBreast OncologyBreast Cancer PatientsMedicineFcgamma Receptors	2009	93
Pharmacokinetics, immunogenicity and bioactivity of the therapeutic antibody catumaxomab intraperitoneally administered to cancer patients Peter Ruf, Michael Kluge, Michael Jäger, British Journal of Clinical Pharmacology	2010	88
Lytic Replication of Epstein-Barr Virus in the Peripheral Blood: Analysis of Viral Gene Expression in B Lymphocytes During Infectious Mononucleosis and in the Normal Carrier State Nadja Prang, Mathias W. Hornef, Michael Jäger, Blood	1997	84
Treatment of Malignant Pleural Effusion With the Trifunctional Antibody Catumaxomab (Removab) (Anti-EpCAM×Anti-CD3) Martin Sebastian, Philipp Kiewe, Wolfgang Schuette, Journal of Immunotherapy	2009	65
Lytic Replication of Epstein-Barr Virus in the Peripheral Blood: Analysis of Viral Gene Expression in B Lymphocytes During Infectious Mononucleosis and in the Normal Carrier State Nadja Prang, Mathias W. Hornef, Michael Jäger, Blood	1997	64
Endoparasites in calves of beef cattle herds: Management systems dependent and genetic influences Michael Jäger, Matthias Gauly, C. Bauer, Veterinary Parasitology Animal PhysiologyAnimal AgricultureAnimal ScienceLivestock ProductionAnimal Health Economics	2005	59

Page 1